The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients

• Eva Pericolini,

  Affiliation Microbiology Section, Department of Experimental Medicine and Biochemical Science, University of Perugia, Perugia, Italy

  ⨯
• Alessia Alunno,

  Affiliation Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy

  ⨯
• Elena Gabrielli,

  Affiliation Microbiology Section, Department of Experimental Medicine and Biochemical Science, University of Perugia, Perugia, Italy

  ⨯
• Elena Bartoloni,

  Affiliation Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy

  ⨯
• Elio Cenci,

  Affiliation Microbiology Section, Department of Experimental Medicine and Biochemical Science, University of Perugia, Perugia, Italy

  ⨯
• Siu-Kei Chow,

  Affiliation Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, United States of America

  ⨯
• Giovanni Bistoni,

  Affiliation Department of Plastic and Reconstructive Surgery, “La Sapienza” Medical School, University of Rome, Rome, Italy

  ⨯
• Arturo Casadevall,

  Affiliation Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, United States of America

  ⨯
• Roberto Gerli ,

  * E-mail: gerlir@unipg.it

  Affiliation Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy

  ⨯
• Anna Vecchiarelli

  Affiliation Microbiology Section, Department of Experimental Medicine and Biochemical Science, University of Perugia, Perugia, Italy

  ⨯